-
DE
The Lipid Accumulation Product Index (LAP) is a clinical marker used to assess visceral fat accumulation and cardiometabolic risk in adults based on waist circumference and triglyceride levels.
The Lipid Accumulation Product Index (LAP) is a clinical marker used to assess visceral fat accumulation and cardiometabolic risk in adults based on waist circumference and triglyceride levels.
The Lipid Accumulation Product Index (LAP Index) is a simple, easily calculated clinical parameter used to estimate visceral lipid accumulation – the buildup of fat in the abdominal area. It combines two readily measurable values: waist circumference (in centimeters) and fasting triglyceride levels (in the blood). This allows for rapid risk stratification without the need for complex imaging procedures.
The LAP Index was first described by Kahn in 2005 and has since become a valuable tool in preventive medicine and cardiometabolic risk assessment.
The formula differs by sex:
A higher LAP value indicates greater visceral fat mass and an increased risk of metabolic diseases. While exact cut-off values may vary depending on the study and population, a LAP above 34 (women) or above 58 (men) is generally considered elevated.
The LAP Index is primarily used in the following medical areas:
Compared to the conventional Body Mass Index (BMI), the LAP takes into account not only body weight but also the distribution of body fat and blood triglyceride levels. This provides more precise information about a person's metabolic risk profile. Compared to imaging methods such as MRI or CT scanning for measuring visceral fat, the LAP is significantly more cost-effective and easier to apply in clinical practice.
Despite its advantages, the LAP Index also has limitations:
The LAP Index is typically assessed during preventive check-ups, metabolic screenings, or when metabolic syndrome is suspected. The physician only needs the patient's waist circumference and a current fasting triglyceride value from a blood test. The calculation is straightforward and does not require any additional technical equipment.
An elevated LAP value should always be evaluated in its clinical context and may prompt further diagnostic steps, such as an oral glucose tolerance test (OGTT), liver ultrasound, or an extended lipid panel.
An elevated LAP Index is not a disease in itself but rather a risk marker. The most important measures to reduce the LAP value include:
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.